Rosiglitazone--under fire
Drzewoski, J.óz.; Grzeszczak, W.ła.ła.
Kardiologia Polska 65(7): 831-835
2007
ISSN/ISBN: 0022-9032 PMID: 17694467 Document Number: 607133
Document emailed within 1 workday
Related Documents
1975: Swedish fire experts on fire hazards in the hospital: fire hazards should be considered with greatest seriousness Sygeplejersken 75(16): 21 32Sorensen, B. 1977: Fire hazards in hospitals and nursing homes. 1. Many patients are injured by fire in institutions Sygeplejersken 77(7): 18-19
1991: Smoke and flame. The experts share their experiences in fire fighting and fire prevention Occupational Health and Safety 60(7): 28-30 47
McGee, E.; Lang, T.L. 2002: A study of the effects of a Micelle Encapsulator Fire Suppression Agent on dynamic headspace analysis of fire debris samples Journal of Forensic Sciences 47(2): 267-274
Ungerer, M. 1995: Fire prevention in the hospital. "Can you carry the fire extinguisher?" Pflege Zeitschrift 48(12): 753-754
Taéron, C. 2006: Rosiglitazone Revue de l'Infirmiere 118: 33-34
Krall, R.L. 2007: Rosiglitazone and the FDA New England Journal of Medicine 357(17): 1776-1777; Author Reply 1777
Oka, Y. 2002: Rosiglitazone (BRL-49653) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 438-441
Yonezawa, N.; Oka, Y. 2001: Rosiglitazone(BRL-49653) Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2195-2199
Scheen, A.J.; De Flines, J.; Paquot, N. 2007: What about the controversy regarding rosiglitazone Revue Medicale de Liege 62(9): 560-565
Scheen, A.J. 2010: Suspension of the commercialization of sibutramine and rosiglitazone in Europe Revue Medicale de Liege 65(10): 574-579
Viberti, G.C. 2003: Rosiglitazone: potential beneficial impact on cardiovascular disease International Journal of Clinical Practice 57(2): 128-134
Bao, Z.-j.; Xiang, X.-d.; Deng, J.-w. 2003: Influence of rosiglitazone on the airway inflammation in guinea pigs with asthma Hunan Yi Ke da Xue Xue Bao 28(4): 424-426; 436
2002: Rosiglitazone and pioglitazone: new preparations. Two new oral antidiabetics both poorly assessed Prescrire International 11(62): 170-176
Cox, S.L. 2004: Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes Drugs of Today 40(7): 633-643
Chen, X.-p.; Yang, W.-y.; Bu, S.; Xiao, J.-z.; Liu, X.-l.; Wang, N.; Zhao, W.-h. 2004: Effects of rosiglitazone and metformin on insulin resistance in high-fat diet rats Zhonghua Nei Ke Za Zhi 43(4): 280-283
Wang, Z-hui.; Luo, F.; Liu, X-mei. 2005: Effect of PPARgamma agonist rosiglitazone on regression of the atherosclerotic plaques in rabbits Yao Xue Xue Bao 40(11): 1051-1053
Trivedi, H.; Lu, N.; Andresen, B.T.; Whaley-Connell, A. 2009: Slower decline of renal function after initiation of rosiglitazone in diabetics -- a pilot study Clinical Nephrology 72(3): 181-185
Bellot-Rojas, P.; Posadas-Sanchez, R.; Caracas-Portilla, N.; Zamora-Gonzalez, J.; Cardoso-Saldaña, G.; Jurado-Santacruz, F.; Posadas-Romero, C. 2006: Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study Journal of Drugs in Dermatology: Jdd 5(9): 884-889
Cox, P.J.; Ryan, D.A.; Hollis, F.J.; Harris, A.M.; Miller, A.K.; Vousden, M.; Cowley, H. 2000: Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(7): 772-780